Mehul Joshi Biography and Net Worth

CFO of Pulmonx

Mehul Joshi has served as the company’s Chief Financial Officer since April 2024 and brings over 30 years of experience in Medical Device, Pharmaceutical and Technology industries. Previously, Mehul was Chief Financial Officer at PhenomeX Inc. until its acquisition in 2023. Prior to PhenomeX, Mehul held senior finance roles at ResMed and Gilead Sciences for almost 20 years, including most recently as Senior Vice President, Finance & Head of Global FP&A at ResMed. Mehul supported multiple business models, evaluated and integrated strategic acquisitions, and enabled exponential growth of both companies during his tenure. Mehul holds a Bachelor of Arts in Accounting and a Master of Business Administration from Rutgers University and is a Certified Public Accountant (inactive).

What is Mehul Joshi's net worth?: The estimated net worth of Mehul Joshi is at least $413.85 thousand as of September 2nd, 2025. Mr. Joshi owns 208,489 shares of Pulmonx stock worth more than $413,851 as of September 17th. This net worth estimate does not reflect any other assets that Mr. Joshi may own. Learn More about Mehul Joshi's net worth.
How do I contact Mehul Joshi?: The corporate mailing address for Mr. Joshi and other Pulmonx executives is 700 Chesapeake Drive, Redwood City, CA, 94063. Pulmonx can also be reached via phone at 1-650-364-0400 and via email at [email protected]. Learn More on Mehul Joshi's contact information.
Has Mehul Joshi been buying or selling shares of Pulmonx?: Mehul Joshi has not been actively trading shares of Pulmonx during the past quarter. Most recently, Mehul Joshi sold 7,936 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $1.60, for a transaction totalling $12,697.60. Following the completion of the sale, the chief financial officer now directly owns 208,489 shares of the company's stock, valued at $333,582.40. Learn More on Mehul Joshi's trading history.
Who are Pulmonx's active insiders?: Pulmonx's insider roster includes Daniel Florin (Director), Glendon French, III (CEO), Mehul Joshi (CFO), David Lehman (General Counsel), Geoffrey Rose (Insider), and Derrick Sung (CFO). Learn More on Pulmonx's active insiders.
Are insiders buying or selling shares of Pulmonx?: In the last twelve months, insiders at the sold shares 11 times. They sold a total of 202,010 shares worth more than $357,453.20. The most recent insider tranaction occured on September, 1st when CEO Glendon E. French, III sold 41,882 shares worth more than $94,653.32. Insiders at Pulmonx own 7.5% of the company. Learn More about insider trades at Pulmonx.
Information on this page was last updated on 9/1/2026.

Mehul Joshi Insider Trading History at Pulmonx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/2/2025	Sell	7,936	$1.60	$12,697.60	208,489
6/2/2025	Sell	8,061	$3.13	$25,230.93	213,925
3/3/2025	Sell	14,384	$7.12	$102,414.08	113,986

Mehul Joshi Buying and Selling Activity at Pulmonx

Pulmonx Company Overview

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Today's Range

Now: $1.99

$1.97

$2.02

50 Day Range

MA: $1.91

$1.17

$2.50

2 Week Range

Now: $1.99

$1.13

$2.89

Volume

185,800 shs

Average Volume

501,065 shs

Market Capitalization

$85.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34